Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system ...

Insilico Medicine ("Insilico"), a clinical-stage, generative AI-driven drug discovery company, today announced the ...

Ai Technology Group Inc. (OTCID:AIPG) (the “Company”) and AVM Biotechnology Inc. (“AVM”, the Washington State company that is the subject of the proposed merger) provide this joint press release. The ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today provided key program updates, including new positive data from the ongoing SOLSTICE Phase 2 trial in chronic hepatitis delta (CHD). Participants receiving ...

Shares of the biotech company surged 1,681% in 2025, making it the best performer in the Stoxx Europe 600 by a wide margin.

Insmed's CEO said months ago that the commercial opportunity for the biotech's newly approved lung disease drug was "huge." ...

Nvidia and U.S. pharma giant Eli Lilly will spend $1 billion building a new joint research lab in the San Francisco Bay area ...

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...

The biopharmaceutical sector finally regained its footing in 2025. Here are 5 issues that could determine whether the renewed ...

NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or the "Company"), a clinical-stage biotechnology company advancing regenerative medicine solutions, today reported the results of an international collaborative ...

The company also announced the appointment of Han Lee, Ph.D., as co-chief executive officer (CEO), and the U.S. Food and Drug ...

Congressional inaction has led to the expiration of the federal government’s SBIR/STTR program, cutting off a biotechnology ...